Largest Swiss (SMI) Pharmaceuticals & Biotech Stocks by Market Cap

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
NOVN Novartis	CHF93.30	3.0%	2.5%	CHF190.4b	CHF97.93	PE23.2x	E10.0%	3.5%
ROG Roche Holding	CHF227.50	2.3%	-19.7%	CHF183.6b	CHF279.39	PE15.8x	E8.7%	4.2%
LONN Lonza Group	CHF532.20	1.1%	-5.9%	CHF38.4b	CHF576.86	PE58.7x	E20.3%	0.8%
GALD Galderma Group	CHF73.00	2.7%	n/a	CHF17.4b	CHF76.71	n/a	n/a	n/a
SDZ Sandoz Group	CHF32.26	2.4%	n/a	CHF13.9b	CHF35.37	PE199.4x	E29.5%	1.4%
BANB Bachem Holding	CHF88.50	8.9%	-3.6%	CHF6.6b	CHF70.80	PE59.3x	E15.4%	0.9%
TECN Tecan Group	CHF340.40	2.7%	-5.7%	CHF4.4b	CHF395.57	PE33x	E9.2%	0.9%
SFZN Siegfried Holding	CHF884.00	2.9%	20.0%	CHF3.8b	CHF1,015.90	PE33.6x	E14.7%	0.4%
DESN Dottikon ES Holding	CHF257.00	1.4%	10.5%	CHF3.5b	n/a	PE41.1x	n/a	0%
SKAN SKAN Group	CHF81.90	0.6%	0.5%	CHF1.8b	CHF95.67	PE70x	E18.7%	0.4%
COPN Cosmo Pharmaceuticals	CHF73.60	3.7%	43.5%	CHF1.2b	CHF93.31	PE1048.6x	E30.4%	2.7%
PPGN PolyPeptide Group	CHF33.55	8.8%	41.0%	CHF1.1b	CHF24.55	PS3.5x	E0.07%	0%
BSLN Basilea Pharmaceutica	CHF43.90	2.5%	-5.2%	CHF529.9m	CHF70.58	PE50.7x	E32.4%	0%
IDIA Idorsia	CHF2.35	11.3%	-72.4%	CHF419.9m	CHF1.72	PS2.3x	E14.7%	n/a
KURN Kuros Biosciences	CHF8.00	21.2%	483.9%	CHF295.2m	n/a	PS8.8x	n/a	n/a
XLS Xlife Sciences	CHF35.40	0.3%	1.1%	CHF201.9m	CHF68.00	PE13.6x	n/a	n/a
NWRN Newron Pharmaceuticals	CHF10.26	4.6%	128.0%	CHF191.2m	CHF14.48	PS21.5x	E51.2%	n/a
MOLN Molecular Partners	CHF3.38	3.8%	-43.5%	CHF112.0m	CHF9.35	PS15.9x	E5.1%	n/a
SANN Santhera Pharmaceuticals Holding	CHF9.40	1.2%	47.6%	CHF106.4m	CHF30.00	PE1.9x	n/a	n/a
CURN Curatis Holding	CHF7.80	-7.5%	n/a	CHF34.2m	n/a	n/a	n/a	n/a
RLF Relief Therapeutics Holding	CHF1.28	4.9%	-79.4%	CHF16.1m	n/a	PS2.7x	n/a	n/a
ADXN Addex Therapeutics	CHF0.067	-9.0%	-51.6%	CHF8.6m	n/a	PS5.2x	E119.0%	n/a
SPEX Spexis	CHF0.069	9.5%	-79.7%	CHF4.7m	n/a	PS4x	n/a	n/a
KNRS Kinarus Therapeutics Holding	CHF16.13	5.9%	-66.7%	CHF3.9m	n/a	n/a	n/a	n/a